Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Ordinary shares, nominal value $0.01 per share
Symbol
MURA
Shares outstanding
17,255,853
Price per share
$2.04
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-5,261,275
Value change
-$10,889,151
Number of holders
0
Price from insider filings
$2.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACORN BIOVENTURES, L.P. 7.6% +22% $3,369,527 +$547,205 1,286,079 +19% Anders Hove 31 Dec 2024
FELDMAN STUART 4.4% $2,005,872 765,600 Stuart Feldman 16 Apr 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA). This represents 0% of the company’s total 17,255,853 outstanding shares.

Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$10,889,151 $2.04 0
2025 Q3 5,321,151 $11,013,094 -$7,685,245 $2.07 58
2025 Q2 8,232,985 $20,335,094 +$3,120,880 $2.47 61
2025 Q1 8,395,072 $10,577,119 -$2,681,464 $1.26 62
2024 Q4 9,375,536 $30,188,503 -$4,619,940 $3.22 71
2024 Q3 9,521,654 $29,799,342 -$4,112,563 $3.13 69
2024 Q2 10,897,746 $34,217,578 -$6,397,175 $3.14 79
2024 Q1 12,252,400 $59,913,404 -$6,550,206 $4.89 94
2023 Q4 13,356,680 $79,068,382 +$79,068,258 $5.92 119